News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Antonio Marra: In an analysis of more than 28k pts, pancreatic acinar cell carcinoma was the cancer type with the highest prevalence of gBRCA2 and HRD features.
photo taken from Antonio Marra/Twitter
Aug 27, 2023, 18:59

Antonio Marra: In an analysis of more than 28k pts, pancreatic acinar cell carcinoma was the cancer type with the highest prevalence of gBRCA2 and HRD features.

Quoting Antonio Marra, medical oncologist at the European Institute of Oncology, on Twitter:

“Our latest publication just out in the Journal of Clinical Oncology. In an analysis of more than 28k patients, pancreatic acinar cell carcinoma was the cancer type with the highest prevalence of gBRCA2 and HRD features. Relevance for both therapeutic and screening strategies.”

For the article click here.
Source: Antonio Marra/Twitter

Antonio Marra cancer Journal of Clinical Oncology OncoDaily Oncology Pancreatic Cancer
Special Coverage
Blog
Nov 16, 2024, 21:19
Zahra Ramji: The unique challenges of conducting clinical trials in low and middle-income countries
Blog
Nov 16, 2024, 21:15
Olubukola Ayodele: Honoured to organise the cancer health disparities meeting as the finale event of LGCW
Blog
Nov 16, 2024, 21:08
Mohit Manrao: 4 Takeaways from Milken Institute Future of Health Summit
Insight
Nov 16, 2024, 21:03
Ultrasound-stimulated microbubbles as a radioenhancer in radiation treatment - Technology in Cancer Research and Treatment
Insight
Nov 16, 2024, 20:35
Kate Dibble: Financial Difficulty Over Time in Young Adults With Breast Cancer
Insight
Nov 16, 2024, 20:28
Naveen Pemmaraju: Our new report on DDX for mediastinal mass in patient with B-ALL
Blog
Nov 16, 2024, 20:04
Paul Sargos: ESTRO pre-meeting courses are here
Blog
Nov 16, 2024, 20:00
Katsuaki Maehara: Non-G12C KRAS mutations
Insight
Nov 16, 2024, 19:57
Praful Ravi: Can oligometastatic prostate cancer be cured with "total therapy"?
Blog
Nov 16, 2024, 18:42
Paolo Tarantino: Focusing on HR+/HER2- Breast Cancer
Blog
Nov 16, 2024, 17:57
Emad Shash: Cancer-Associated Thrombosis
Insight
Nov 16, 2024, 17:21
Nirmala Bhoo Pathy: A roundtable discussion on cancer financing at the Royal Society of Medicine